ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000956.1|Andrimid_1 # 2 # 229 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.482	BGC0000956.1|Andrimid_1 	2	229	+	Loose	400	22.3274	Erm(34)	29.55	3000600	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATCAGCGAAAATTTGAATCTATCAACTGATGGTGATGTATTGCATTTAGGCCAGCACAGCGACAGAGCTATTGCCGTCGAAACCAGCCAGAGCGCCATCAGCGGCGATGAATATATCGTGGCAACAGGAGGCGTTTACCTCCCGTTGCGAGATAACAGAGGCGTCCGTATTCCACTTTGTGCGTTACAGGATTACAGCCTGATAAAACTTTATCCCGGTCAGACGTAA	ISENLNLSTDGDVLHLGQHSDRAIAVETSQSAISGDEYIVATGGVYLPLRDNRGVRIPLCALQDYSLIKLYPGQT	MTKKMNKYNGKKLSRGEPPNFSGQHFMHNKRLLKEIVDKADVSVRDTVLELGAGKGALTTILSERADRVLAVEYDQKCIEALQWKLVGSKNVSILHQDIMKVALPTEPFVVVSNIPYSITTAIMKMLLNNPKNKLQRGAIVMEKGAAKRFTSVSPKDAYVMAWHMWFDIHYERGISRSSFSPPPKVDSALVRIVRKQHPLFPYKEAKAMHDFLSYALNNPRAPLDQVLRGIFTAPQAKKVRQAIGVKPETPVAMLHARQWAMVCDAMVRHVPKVYWPRRKR	26.69	gnl|BL_ORD_ID|7|hsp_num:0	11			183	315	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000956.1|Andrimid_2 # 901 # 1161 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.475	BGC0000956.1|Andrimid_2 	901	1161	-	Loose	550	24.2534	TER-2	39.39	3007007	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	TER beta-lactamase	ATGACTTCTCATTTTCGCGACGTAGCTTATCTATGTACAGGCGCTCGAAAACTGCACGGCCAACATGAGAAAGTAAAAGGATTACACACTGGAGGATGCAAAGCGCACGGCTTCTTTTCGGCGGACAAACTGGGTCCAGTTACCTTCGGTCAACGACCTGTTATTCTCTTTACGACGGTCTTTTTTGAGTTTCCTCAACAGACTTCGGTTAGCAACATCACGCAGATCCGTACCGGAGTGGTTCAGTGCTGGAGAAGATAA	MTSHFRDVAYLCTGARKLHGQHEKVKGLHTGGCKAHGFFSADKLGPVTFGQRPVILFTTVFFEFPQQTSVSNITQIRTGVVQCWRR	MRHSLFAPILLLALFALPAWAHEATVNQVKAAERQLEARVGYAELDLASGRLLASYRPDERFPMMSTFKVPLCAAVLARVDAGEEKLDRRVRYRQQDLVEYSPVTEKHLADGMTVAELCAAAITLSDNTAANLLLASVGGPQGLTAFLRRSGDQTSRLDRWETELNEALPGDARDTTTPQAMAKTLRNLLTGSVLSAASRQQLRSWMVDDKVAGPLLRSALPHGWFIADKTGAGNRGSRGIIAALGPDGQPARIVIIYLTGTEASMDERNRQIAEIGETLVKHW	30.28	gnl|BL_ORD_ID|4600|hsp_num:0	5671			627	726	
BGC0000956.1|Andrimid_3 # 1315 # 1599 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.379	BGC0000956.1|Andrimid_3 	1315	1599	+	Loose	500	25.7942	OXY-2-8	40.62	3002403	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam	antibiotic inactivation	OXY beta-lactamase	ATGAATATAAATGAAGTAATCAACCATATTAAAGAAAAAATTATCTTTGAAGATCTCGAACTCAACGAATGGGGACATGAATTGTCAGACATTAAAGATGACACGCCTCTATTGGCTGAAGAAGGTTTGGCTTTAGATTCTGTCGATGTCCTGGACATTTTTGTTGGCATCCAAAAAGAATACAGTATTGACCTGGGGGAAATCACCAGTGAATTGATGGAAAAACACTGTCAATCTCCTTTGACTCTGGCTGAATTGGTTATCGATAAATGTGGTGCTCGCTGA	MNINEVINHIKEKIIFEDLELNEWGHELSDIKDDTPLLAEEGLALDSVDVLDIFVGIQKEYSIDLGEITSELMEKHCQSPLTLAELVIDKCGAR	MIKSSWRKIAMLAAAVPLLLASSALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQILYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMTLAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDERDTSTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAGDYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKNRKEVLAAAAKIVTEGL	32.41	gnl|BL_ORD_ID|185|hsp_num:0	203			276	372	
BGC0000956.1|Andrimid_4 # 1676 # 2374 # 1 # ID=1_4;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.353	BGC0000956.1|Andrimid_4 	1676	2374	+	Loose	500	25.0238	OXA-491	40.54	3005725	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	TTGTTCAACCCGCAGATAGTGCCCGATAACATGAAAACACTGATTTTAAATAATTATCAATCAGCAATCGTTGATTGCTTAGAGGATAATCTCACTGAGAACAGCGTCGACTTGTTTTCATTGAATGATAGCGATGATGTGAAAGATGACCTGATAAAGAGGTTGGAAACGGATGGCCTGATATATGAAAATGTTATTGTTGATTTAAGATATAATGAAGAGGAATTGCTGAGGTCAATTTTTAATGGCGATGCCAACCATAAAAGTAATGAAATTTTTTCAGGTAGGTTAGTGGATGATATACACTATTTAATGCAGGTGTTGAAGCGAATAGTGTTGACTAACATGAAATTAGATGGCTCCAAGTTTTTCTTTTTGTTAAAAGATGATTCGTTTGGTTATCTGGATACTAATGATAGCTCGCCCACATACAATGAATCCGTAATGTCAATGTCGAAATCCCTGGCGAAAGAATATTCGCGGTACAATATGGTTTTCAACTCGCTGATTATTCAGCCTGAATTAAAAGAGCTAACTCTCAACAGGCAGAGCAAAGATCTTTTAAAAAATTACGCGTTAAAATATAAATCAAATAGCTATTTAGATGTCTCTAATTTCATTTTATCGATGATTGAAAATAACTTCCCAATTAATGGGGCGACGATACGGCTGGGAAATGGAGTGGTTGACTATGTCTAA	MFNPQIVPDNMKTLILNNYQSAIVDCLEDNLTENSVDLFSLNDSDDVKDDLIKRLETDGLIYENVIVDLRYNEEELLRSIFNGDANHKSNEIFSGRLVDDIHYLMQVLKRIVLTNMKLDGSKFFFLLKDDSFGYLDTNDSSPTYNESVMSMSKSLAKEYSRYNMVFNSLIIQPELKELTLNRQSKDLLKNYALKYKSNSYLDVSNFILSMIENNFPINGATIRLGNGVVDYV	MNKKIKLIFILIFSINLFANDVELENLFKKYQVEGTLVLESLNTKKVDIYNEKRANTSFSPASTFKIPNTLIALNEGVVNKDSIIVWDKKVREFDAWNKDQTLQSAFKSSCVWCYKEFASKIGVEKYSKYLKELNYGNKTIGKDVTDFWLDESLRITAFEEIRFLKQLQANNLAFKQEDINLLKELMIDEKSENYVVRAKTGWEGKYGWYVGYVETKNDVWFFALNIDTKTKEDLAKRKALTLEALKTKGIIN	91.70	gnl|BL_ORD_ID|3760|hsp_num:0	4830			645	756	cloxacillin; oxacillin; cefalotin
BGC0000956.1|Andrimid_5 # 2352 # 3116 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.476	BGC0000956.1|Andrimid_5 	2352	3116	+	Loose	300	28.4906	lnuA	26.44	3002835	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic inactivation	lincosamide nucleotidyltransferase (LNU)	ATGGAGTGGTTGACTATGTCTAAGAAAGTCGTCCTCATTACTGGGGGAGGAAGAGGGATCGGGCGAGAGATCTGCATGGAATTCGCCTCTGAAAATACCCATATCGCGTTAACGTATACACGCGATGCCCGTAGCGCAGAACAGGTCAGGCAGACGCTGGAAGATAGCAATGTAACTTGTTCAGTTCATAAGTTAGATGTCCAGGACTTTCACATGTGTCAGTCAGTCGTCGAAACGGTTGAACGCGAGTACGGGACCATCAATATTCTGGTCAATAATGCCGGGGTGACGCTGAGTAAACAATTCGTCAATTGCGATGAAGCGGAAAACAAAGCTGTGTTATCGACCAACCTTCAAGGCGTGATGAACATGACGCTGGCGACGGTACCTTCTTTGAAAAAGTCGACCAGTAATGACGAACCCGGACGAATTGTTAACATATCATCTAACACCTCTCTATGTGGAAATGCAGGCCAGGTCGCCTACAGCGTGACGAAAGCTGGAGTGAATGGTTTTACTCGCTTATGCGCAAGAACGCTAGCCAGTCACAATATATTTGTGAATGCCGTTGCACCGGGCTACATCGATACTGATATGACCCAGGATCTTCCTGAAAGCGCCTATTCCCACGTGTTACAGGTATCAGCAATAAAGCGAACAGGCTGTGTGAAAGACGTAAGTTCAATCGTGCGATTGTTGTGCGGCGATAACTGTCATTACATGACTGGTCAGGTGCTCCATATTGATGGCGGGAAGTTTTGTTAG	MEWLTMSKKVVLITGGGRGIGREICMEFASENTHIALTYTRDARSAEQVRQTLEDSNVTCSVHKLDVQDFHMCQSVVETVEREYGTINILVNNAGVTLSKQFVNCDEAENKAVLSTNLQGVMNMTLATVPSLKKSTSNDEPGRIVNISSNTSLCGNAGQVAYSVTKAGVNGFTRLCARTLASHNIFVNAVAPGYIDTDMTQDLPESAYSHVLQVSAIKRTGCVKDVSSIVRLLCGDNCHYMTGQVLHIDGGKFC	MKNNNVTEKELFYILDLFEHMKVTYWLDGGWGVDVLTGKQQREHRDIDIDFDAQHTQKVIQKLEDIGYKIEVHWMPSRMELKHEEYGYLDIHPINLNDDGSITQANPEGGNYVFQNDWFSETNYKDRKIPCISKEAQLLFHSGYDLTETDHFDIKNLKSIT	157.76	gnl|BL_ORD_ID|22|hsp_num:0	27			75	273	lincomycin; pirlimycin
BGC0000956.1|Andrimid_6 # 3135 # 5339 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.483	BGC0000956.1|Andrimid_6 	3135	5339	+	Loose	700	30.4166	pp-flo	24.38	3002812	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAAAGGTTCAATTGTAGTTTCTGGTATGGGGATCTACACCCCACCTGTTGCTGATTTAGACGAAGTAACACGTTTTTCTTCAGATCAGCATCGGTTAATTAACAACCCTGAATACAATGAGTTGGGGATTAAGAATGCTACGGTGTCCGTCTTTAATAAAAAGAGGACGGAACCCTTTGGCAAACAAGGCTGGGTGAATAATGCCTCCATTTTCGCGCTGAGAGCCACGGAAGCTGCCATCAAAAACTCAGGAATCAACCTGGCTGAGTACGATATGCGTCGAGTCTCTGTCGTTTTAGGCAGCTATAATTCCGGCACTGACAGCTACTCAAAAATGTTTAATAAGGTGCTAAACAATGAGCAGGACAGCGTATCGCATAGCGAACTGATGTCTTCAATGTTATCGCATTGTGGCAACGCTATTGCCGCTCGTTACAATTTACAAGGGAAGAAAATTGTTGTCTCTTCCGCCTGCTCTTCGAGCTTGACGGCAATAGGGATAGCGACGGATCTGCTTCATACCGATAAAGCGGATGTGGTGATCTGTGGTGGTTCTGATTGTATCGATCTCCCCGTCGTAGCTGGTTTCAACAGTCTGAGTGCGTTGAATGAAGGCCGGTGTGCGCCATTTTCTGAGCCTAAAGGGATCAACTTAGGGGAAGGCGCGGGCATACTCATTCTCACCAAAAACAAAGATAGCGTTAATAATAAGTGGTTAGTCACCGGTTGCGGGGTATCCAGCGATGCATATCACGAAACCTCCCCAGAGCCGAATGGAGCGGGTGCTACTCAGGCCATCGACGCAGCATTATCGGCCGCAGGTCTGAGTAGAAATGACGTCGATTTGATTTCAGCACATGCTACCGGTACCGGTGCAAATGATATCCCTGAGTCAAAAGCGTACGAGAAACTATTTGGTCTTGATGTGCCAGTCAGTGTAATGAAACCATTTTACGGCCACACTTTAGGGGCTTCTGGCATCATAGAGTTGATTAGTGTCTTGTCCCTGCTGGATAGGGGCATCACGCCAGAAAATAACAACCTGAGAGAACTGCGGGAAGGGTGCAGCCCCATAAACCTCCACTACAGGGATTACCCTGCCGACAAAATCCATACCGTCCTGGCAAACAGTTTTGGATTTGGTGGCAGTAACAGTTCCGTTATTGTGACTAAACGAGCGAATGAACGTCCCGTCAAATATACCCGGTCAGCCATACCTATTATGAAAGCAAGTGCGAATGACGGGGTGGCAAAAACGGTTATTGGCACCAAAACTGGCGTCGTGAAGGAAGAGTGTCAGATTCATCTGCAAAACAAGAGGTTCAAACGCGACTCACCAGAAATTAAATACTGTATCGAGTCGGTAGGCGATGTGATGAATGGTTTTGAGCAGGTCTTACAAAGTAATGCCCGGGCAGGGGTCATTACGGGCAACTCACTGCGTCCACAACGCTGTCTGGAAAGTTTCCTGACGTCGATCTATGACGGTGATCCCAGGTATGCAAGTGCGCGTCACTTTCCGGGACATATTGTCAGCGCAACCTGTGGTCAGGTCTCTATCGCACACAAGATAATTGGTCACTCCACGGTGCTGTGCAGTCCGACAGCGGCGTTCGAATATACTGTGGATCTTCTTAGAAATGATACGCAAGACTTTATGATTGCCTGTTCAAGTGACGATGTGACACCGGTTCAGGAAGATCTTGTCCATCACGTTTTTGCCGGGGCAGACTATGTGATGGCTAAAGGAAGTGCAGCCCTTCTTCTTTCGGGCCGACAGCAGCTTTCCAGCAGTGAACACGCGCCTGCAGCATGGGTTCGCAGCATGCTTCATTCGTCCTGGAACGGACTGGTGCTAAGGAATGATGAACAGTTCCATCGCCTGCTGGAGAGGCTTGTCCTCGATTCCCTTGAAGAAGCCTGCATGAGTTTTGCTGAAATAGAGCATTGCCTCGTATCAAATGCGCTGATGGACAGCAGCATTGTCGATGGGGTGAAACAGGTGTTGAGCCAATATCACCCCCATCTTGTTGTGGAAAGTAAGAAGGATAAGAGACTCTCATCCGACTTTATGACGCATATCGTTGACGCAACTGAGATGATTTCGACAGGCGTTAAGAGCCACGTAATGGTGATAGCGATTGATCTGTCCTCTAATGTGGGCGCATGCATCATCTCAAGCCAGGACAGTCAGACGAGATAG	MKGSIVVSGMGIYTPPVADLDEVTRFSSDQHRLINNPEYNELGIKNATVSVFNKKRTEPFGKQGWVNNASIFALRATEAAIKNSGINLAEYDMRRVSVVLGSYNSGTDSYSKMFNKVLNNEQDSVSHSELMSSMLSHCGNAIAARYNLQGKKIVVSSACSSSLTAIGIATDLLHTDKADVVICGGSDCIDLPVVAGFNSLSALNEGRCAPFSEPKGINLGEGAGILILTKNKDSVNNKWLVTGCGVSSDAYHETSPEPNGAGATQAIDAALSAAGLSRNDVDLISAHATGTGANDIPESKAYEKLFGLDVPVSVMKPFYGHTLGASGIIELISVLSLLDRGITPENNNLRELREGCSPINLHYRDYPADKIHTVLANSFGFGGSNSSVIVTKRANERPVKYTRSAIPIMKASANDGVAKTVIGTKTGVVKEECQIHLQNKRFKRDSPEIKYCIESVGDVMNGFEQVLQSNARAGVITGNSLRPQRCLESFLTSIYDGDPRYASARHFPGHIVSATCGQVSIAHKIIGHSTVLCSPTAAFEYTVDLLRNDTQDFMIACSSDDVTPVQEDLVHHVFAGADYVMAKGSAALLLSGRQQLSSSEHAPAAWVRSMLHSSWNGLVLRNDEQFHRLLERLVLDSLEEACMSFAEIEHCLVSNALMDSSIVDGVKQVLSQYHPHLVVESKKDKRLSSDFMTHIVDATEMISTGVKSHVMVIAIDLSSNVGACIISSQDSQTR	MTTLHPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSLYMVMLGVGQVIFGPLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAMLVATFATVRDVYANRPEGVVIYGLFSSVLAFVPALGPIAGALIGEFLGWQAIFITLAILAMLALLNAGFRWHETRPLDQVKTRRSVLPIFASPAFWVYTVGFSAGMGTFFVFFSTAPRVLIGQAEYSEIGFSFAFATVALVMIVTTRFAKSFVARWGIAGCGRVGWRCLFAAVLLGIGELYGSLNSSPSSYRCGLSRSVLSSRCPLPRTALLAEFDDIAGSAVAFYFCVQSLIVSIVGTLAVALLNGDTAWPVIC	196.26	gnl|BL_ORD_ID|1895|hsp_num:0	2058			693	1122	chloramphenicol; florfenicol
BGC0000956.1|Andrimid_7 # 5530 # 5802 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.396	BGC0000956.1|Andrimid_7 	5530	5802	+	Loose	700	23.0978	MOX-13	35.56	3006478	protein homolog model	n/a	n/a	cephalosporin; cephamycin; penam	antibiotic inactivation	MOX beta-lactamase	ATGCTATTTTACAGTGACTGTGTTTTTTTTGAAGGGCATTTCCCCGATAACCCTATAGTTCCGGGTGTACTACTGTTAGATACCATCTATGATCATCTGTTAAAAAAGGGAATGGAGAATATTTCCGGGATTGATAATGCACGGTTTTACAAGACGGTCCTGCCCAACGAAAAAGTTATTGTGAAAATCAATGACCAGGCGGATAAAGTCGTGTGCACCGTCAAAAACGACGCAGGTAAAATACTCAAAGTCAGTTACATAAAAGCGCAATAA	MLFYSDCVFFEGHFPDNPIVPGVLLLDTIYDHLLKKGMENISGIDNARFYKTVLPNEKVIVKINDQADKVVCTVKNDAGKILKVSYIKAQ	MQQRQSILWGALATLMWAGLAHAGDKAATDPLRPVVDASIRPLLKEHRILGMAVAVLKDGKAHYFNYGVADRERAVGVSEQTLFEIGSVSKTLTATLGAYAVVQGSFELDDKASLFASWLKGSAFDNITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSPGSHRQYANPSIGLFGYLAASSMKQPFDRLMEQTILPGLGLYHTYLNVPEQAMGHYAYGYSKEDKPIRVTPGMLADEAYGIKTSSADLLRFVKANISGVDNAAMQQAIDLTHQGQYAVGEMTQGLGWERYAYPVSEQTLLAGNSPAMIYNANPAAPAPAATGHPVLFNKTGSTNGFGAYVAFVPAKGIGIVMLANRNYPNEARIKAAHAILTQLAR	23.50	gnl|BL_ORD_ID|3704|hsp_num:0	4774			690	825	
BGC0000956.1|Andrimid_8 # 5804 # 6646 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=ACA;rbs_spacer=15bp;gc_cont=0.427	BGC0000956.1|Andrimid_8 	5804	6646	+	Loose	300	27.7202	poxtA	30.51	3004470	protein homolog model	n/a	n/a	tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGATCGATTATTCAACTCAATCAGATATTACGGCCTTAGGCGATGCAGCGCCTCATCTCGATGTGAACGACAGCTCACTGCTGAGTATTGCCAGAAGTTGTCGTAATCTTATCGAGCATCAAAGCGGTGTCAATGCTCACAAGATCCCTCTGTCCCGGCACAAAGACTTCGAACTGCGCACGGTCACAGAAGTTCTGCAAGAAGCGACGAGACGCGGGCTGGATTTAACAACAGAGAATCCTTTTGAAAAGAAAATCATTGGCAATTGCCAAACGATTTCATTGTTATGTCTGGGTATCCTGCGTGAGTTATCGATCCCGGCGCGATATCGATTCTGCCTGTGTGAATATTTTGAACCCAATTCCTACGCGGAACACATCGTCCTTGAGTACTGGTGCTCTTCAGATAAAAAATGGAAAATTCTGGATCCAACGGTCACGCACGAAATTATTGAAAAAAACCAGACTCAATCCTTTATCGATTTCGAATTTGATAACATTCCGAGAATAAAGTCCAACCTCTTTATCGATCTGTGGAAAAAATATCGGCGCGGTGATTTAGATCTTAATGCCATTCATCATCATTCGTACAGAAAGATCCTTGGCCTTGAGCGATTCGTGTGGAGGACACTACAGGATGTTCTGGCTTTACATAAGGTGGAGCTTTTTTACTGGGACTACTTTGATTTTAAGCAGTATGTGAACGAACCCCAACGAGTGGATGAGATCATTGAAAATATCGATGAAAGTAGAAAAGAGATGAAGAGCATTAATCTTGACTTCTCAGGGTTCATTAACTTCCATCCTTATCAACGAGAGTACAAGTCATGCCAGAGTTTGTGA	MIDYSTQSDITALGDAAPHLDVNDSSLLSIARSCRNLIEHQSGVNAHKIPLSRHKDFELRTVTEVLQEATRRGLDLTTENPFEKKIIGNCQTISLLCLGILRELSIPARYRFCLCEYFEPNSYAEHIVLEYWCSSDKKWKILDPTVTHEIIEKNQTQSFIDFEFDNIPRIKSNLFIDLWKKYRRGDLDLNAIHHHSYRKILGLERFVWRTLQDVLALHKVELFYWDYFDFKQYVNEPQRVDEIIENIDESRKEMKSINLDFSGFINFHPYQREYKSCQSL	MKGKNMNLAFGLEEIYEDAEFQIGDLDKVGIVGVNGAGKTTLFRLLLGELELDNGSLTSGNARIGYLPQEIVLEDEDITVWDFLFEGRPIKKYEQELEEIYKKLETAVNAEQEALLARMGTLQERLEYFDFYEAETILLEFADKMSIDAELYHRPMRELSGGQKSKMAFARLLYSKPEILLLDEPTNHLDVSTKDFVIKYLKNYRGSVLIISHDIDFLNRIINKIMYINKATHKISVYDGDYYIYKKKYAEEQRIREMAIVQQEKEIKELSDFVQKAKQASQTNHHLKRMGQERALRLDKKRGELQKRNRLYKRVKMDIRPKREGAQVPLEVENITFHYSGYPTLYQNLSFQINGRERFLVVGENGVGKSTLLKLMMGILSPDEGCIRFNQKTDIAYYAQELEQLDENKTVIDNVESEGYTPWQIRAVLSNFLFYDDDVNKKVSVLSPGEKARVALCKILLQKANLLILDEPTNHLDPETQKIIGGNFNLFEGTIIAVSHNPSFVEQIGISRMLILPSGRIEPYSRELLEYYYEINGSVAKF	51.66	gnl|BL_ORD_ID|2510|hsp_num:0	2904			651	819	tetracycline; doxycycline; linezolid; chloramphenicol; florfenicol
BGC0000956.1|Andrimid_9 # 6631 # 7026 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.434	BGC0000956.1|Andrimid_9 	6631	7026	+	Loose	2200	25.7942	rpoB2	30.77	3000501	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	ATGCCAGAGTTTGTGAAAGGGGCTCATGCTCAACCTTTTTCTTTTATTGGTACCGTTGAGGATATGTCTGAGCATGAAATGACGGCCAGGGCAGATTTCTCTGCAGAGAAGACCTACAGGCAGTGTTGCCAAAATGCATGGCCACTGATTGTTGAATCATTAGCTCAGGCAGCCGGTATCCACATAAAAAACCAACTGGATCCTGATTATAGTGGCTATTTAGTCGGTTTGGATAACCTGAATATTCAGCACGCTGGTGATATCAGACCCAACTATCACTTAGTGACCAAAATAGTCAGCCGTCTTGATTCGAAATACCTGTATCACTGCGAAGCATTCAGCAGTACCAATCATTCGATCCTTTCTTGTCACATTCTACTGTCAAACTCAGATTGA	MPEFVKGAHAQPFSFIGTVEDMSEHEMTARADFSAEKTYRQCCQNAWPLIVESLAQAAGIHIKNQLDPDYSGYLVGLDNLNIQHAGDIRPNYHLVTKIVSRLDSKYLYHCEAFSSTNHSILSCHILLSNSD	MLEGRIVTVSSRTESPLAAPGVPGAPRRLSFARIREPLAVPGLLDIQTESFGWLIGAPDWCARAAARGTEPVAGLAEVLAEISPIEDFAGTMSLTLSDPRFEEVKASVEECKDKDLTYAAPWFVTAEFVNNNTGEIKSQTVFMGDFPMMTAHGTFVVNGTERVVVSQLVRSPGVYFDHAIDKGSEKDVHSARVIPSRGAWLEFDVDKRDTLGVRIDRKRRQPVTVLLKALGWSAERIAERFGFAPLIMASLAKDNVAGTDDALLEIHRKLRPGEPPTKESAQNLLANLFFTEKRYDLARVGRYKIDKKLGLRAPGAPRVLTEDDIAATIEYLVRLHAGERTMIAPGGVEVPVEVDDIDHFGNRRVRTVGELIQNQIRVGLSRMERVVRERMTTQDVEAITPQSLMNIRPVVAAMKEFFGTSQLSQFMDQRNPLASLTNKRRLSALGPGGLSRERAGLEVRDVHYSHYGRMCPIETPEGPNIGLMGYLSVYARVNPFGFVETPYRRVVDGRVTDEVDYLTADEEDRHVVAQANEPLDAEGRFLAARIPVRRKNSEVELVDSAAVDYMDVSPRQMVSVATAMIPFLEHDDANRALMGANMQRQAVPLIRSEAPIVGTGMELRAAVDAGDVVVNEKAGVVEEVSADYVTVMADDGTRKSYRMRKFNRSNQGTCSNQRPIVDEGQRVEAGQVLADGPCTENGEMALGKNLLVAIMPWEGHNYEDAIILSQRLVEQDVLTSIHIEEHEIDARDTKLGAEEITRDIPNVSDEVLADLDERGIVRIGAEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGESGKVIGIRVFSREDDDDLPPGVNELVRVYVAQKRKIQDGDKLAGRHGNKGVIGKILPTEDMPFLPDGTPVDIILNTHGVPRRMNIGQILETHLGWIGKAGWKVEGNPEWAKDLPEEMWEAPADSNIATPVFDGAREEELTGLLGSTLPNRDGERMVDDNGKAVLFDGRSGEPFPYPVAVGYMYILKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYGAAYTLQELLTIKSDDVVGRVKVYEAIVKGDNIPEPGVPESFKVLLKELQALCLNVEVLSAGAAVELAHGVDDDHERTAANLGINLSRAESITETELSG	11.27	gnl|BL_ORD_ID|2431|hsp_num:0	2831			1902	2058	rifampin; rifaximin; rifabutin; rifapentine
BGC0000956.1|Andrimid_12 # 9041 # 9304 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.360	BGC0000956.1|Andrimid_12 	9041	9304	+	Loose	850	23.483	OpmH	26.03	3003682	protein homolog model	n/a	n/a	disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGAAAAATCTGAGATTGAACAGACGCTTAAAAATGAAATTAAATTAATAAACCATTACAGTGATAGCGTAGAGATAGATGCAGAGGTTAAACTGAGAGAGATTCTCGATTCGGTAGATATTCTTCAGTTTGTGTACAAAATTAATAAAGATTACGGTCTGTCATTTGGCAGTAATATTGGCGATGAAAAGTATTTAGACACGCTCGATGGAGTCGTTTCCTGGGTGCATTCTGCAATCAATAAAAAGGCCGAAGATGACTGA	MEKSEIEQTLKNEIKLINHYSDSVEIDAEVKLREILDSVDILQFVYKINKDYGLSFGSNIGDEKYLDTLDGVVSWVHSAINKKAEDD	MLRRLSLAAAVAAATGVAWAAQPTPLPTKTDLISVYKEAVDNNADLAAAQADYLARKEVVPQARAGLLPQLGAGARVGDTRIAFDERPATVKRNSQVVQATLSQPLFRADRWFQWQAAKETSDQARLEFSATQQDLILRSAETYFTVLRAQDNLATSKAEEAAFKRQLDQANERFDVGLSDKTDVLEAQASYDTARANRLIAEQRVDDAFQALVTLTNRDYSAIEGMRHTLPVVPPAPNDAKAWVDTAVQQNLRLLASNYAVNAAEETLRQRKAGHLPTLDAVAQYQKGDNDALGFANSAANPLVHYGKYVDERSIGLELNIPIYSGGLTSSQVRESYQRLNQSEQSREGQRRQVVQDTRNLHRAVNTDVEQVQARRQAIISNQSSLEATEIGYQVGTRNIVDVLNAQRQLYAAVRDYNNSRYDYILDTLRLKQAAGTLSPADLEALSAYLKQDYDPDKDFLPPDLAKAAAEQLQSKPRQQY	18.05	gnl|BL_ORD_ID|2005|hsp_num:0	2195			1101	1320	triclosan
BGC0000956.1|Andrimid_13 # 9297 # 10865 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.419	BGC0000956.1|Andrimid_13 	9297	10865	+	Loose	1000	110.538	almE	22.68	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGACTGAAAGTAATCTATTGTCGATGATAAGACGATTTGAGGGTAATGATAACGTTGCCTATTACGACTTTGAAAGAAAAATGACATTTTCAGAACTGTATCTGGAAGTGGTTATGATAATAAATTACTTTGAATCGGAAAATATAATTCAAGGTAAAAGAGTTGTCTCATTTTTGGATAAGTCATTTTCAGAGTATGCCCTTTTCTATGCGTGCTTATTGAAAGGCGTCGCTTTTTGCCCATTGGATAAAAGCCTGCCTGTCAGTCGGTTGGCGATGATCATCTCGGATCTTCAACCTGATATGGTCATAGCGGAGGACACCTATACAGGTGAAGAGAACGCTTTCAGGCAAAACTTGTTAATTCCACATGAGTGTGTGGTGTCAAATGGACCTGTTAGCGTATTAACCGACGTTGATGCTCGTGATGAAGAGAATGTGACGGATATTGATAGAGATACCGTCGCGTACATCATCTTTACTTCCGGGTCGACGGGGAAGCCTAAAGGGGTGCAAATTACGCACGAAAACCTGAATTTTTTCTTAGAGGCGCTGTATCCCCGGTACGTCAGTGAGCAATCAGAGAACTATTTGTCAATTGGTCCACTGTATTTCGACATGACCATACTTGACAGTATGGTACCACCTTTGTATGGGCACTCGGTCTACTTGTACAAGGCGCCTTTCATACCGGCAATTTTCTCTGGCATCATTGAAAAATACCGGATCACCCGGTTGAGCTGTGTCCCTTCAGTGCTGGAAATATTGTTGCCACAGCTTCACGAGGCGACGGGCTTTGACAAGCTTCATTCTCTTAACCTTATCCTGTTTGGTGCTGAAAAACCGCACGGGCAATCCATAAAGACATTGCTGCAACACATCCCCGATCTTAAAGTTATTAACGCATACGGCCCGACAGAAGGAACCATGTGCTGCTTTTCTTCAGAGATCACCCTCGATTCCTTAGCTGGCGATATCAGTATCGGTAAGCCATTTGATGGCACCAAATACTTGCTCGAAACCCGCTCCGGTTTCTCAAGTTCCGGAGAAGGAAAACTATTGATATCTGGCAAGCAAGTCATGAAAGGTTATATTAATCAGTCACAGGTTGATAACCCATTTATACTTGTTGGCGGTGAGCAATACTATTCTACCAATGATGTCGTTAGAGTGGATGATGAGGGTTTTTTCTACTTTCTTGGACGATCGGATGATGAAGTAAAACTGAATGGATTCAGAGTCCATCTGCAGGATGTTGCGGAGAATATTAAGAAAGTACTGAATATTGGCGATTTGTTTCTACATAAGCACACGGATAACAACAAAGATTATTTGGTTCTTTCATACGAGAGTACGTTGTTGCTAAATCCGGAAGAATGTATTTCTTTGTTAGGAAAGCGGCTGCCAAAATATATGCTCCCAAATGTCTTCGCCATTTTTGACTCACTACCTAAGCTGAGGAGCGCAAAGTTAGACAGGAATAAAGTCAAAGATTCTGTCAACGCAGAGTTTATCCGCTCTAAAGGATGTTTAACCGACAAGAAACTCATCTCATTACATATTAAATAA	MTESNLLSMIRRFEGNDNVAYYDFERKMTFSELYLEVVMIINYFESENIIQGKRVVSFLDKSFSEYALFYACLLKGVAFCPLDKSLPVSRLAMIISDLQPDMVIAEDTYTGEENAFRQNLLIPHECVVSNGPVSVLTDVDARDEENVTDIDRDTVAYIIFTSGSTGKPKGVQITHENLNFFLEALYPRYVSEQSENYLSIGPLYFDMTILDSMVPPLYGHSVYLYKAPFIPAIFSGIIEKYRITRLSCVPSVLEILLPQLHEATGFDKLHSLNLILFGAEKPHGQSIKTLLQHIPDLKVINAYGPTEGTMCCFSSEITLDSLAGDISIGKPFDGTKYLLETRSGFSSSGEGKLLISGKQVMKGYINQSQVDNPFILVGGEQYYSTNDVVRVDDEGFFYFLGRSDDEVKLNGFRVHLQDVAENIKKVLNIGDLFLHKHTDNNKDYLVLSYESTLLLNPEECISLLGKRLPKYMLPNVFAIFDSLPKLRSAKLDRNKVKDSVNAEFIRSKGCLTDKKLISLHIK	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	93.88	gnl|BL_ORD_ID|4935|hsp_num:0	5928			102	1650	colistin A; colistin B
BGC0000956.1|Andrimid_14 # 11066 # 12754 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=ACA;rbs_spacer=15bp;gc_cont=0.472	BGC0000956.1|Andrimid_14 	11066	12754	+	Loose	1000	103.219	almE	26.7	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGCAAGATGATGACTTGAAAAATGTGCTTCGCACGGTAAGAGCGCGTTATGGACAAAAAAACGCGATCGTGTTCAATGAGGTGGCCTGTTCATATCAGGAGTTAGATCGACGCATTGGAATCTGCAATCAGGCTATTTCACGCAGCGATACAGCGGTCATTATCAATGTCAAAGATAAACTGAAAGCCATCACACTGATGCTAGCCGCCATAGACTGTGGTGTAACATTTATACCGGTTGATGGCGATCGGCCTCGTTCGTTTTTGACTAAAATCGCGACGAAATTCCCTCAGGTTCGGGTGATTAATGATGTGTGTTTCGATACGGGGCTGCTTGTCTCACATCCCCTGACGCATCATGGACATGCGCAGGTACTTCCTCGTGCTGTTGAGCAAGGTGTGATGTCTGTCATGTACACATCAGGTTCCACGGGGGAACCCAAAGGCGTGCAGGTCAGAGCGAGTTCTGTGCTCAATTTGCTACATCGTCCCTCTTTCATTTCCTTGAGTGATGAAGACGTTGTGGCATCTTATTCGTCACTCTCCTTTGATGCGTCCACGTTCGAAATCTTTACCCCCTTGCTCGCTGGCGGCACGCTGGTGCTGCTGGATAAGATGGTGGTGCTGGATGAGGCGAGTCTTCTTCATGCCATTGAGCAATACAGAATAACCTGCATGTGGATGACGGCCGGACTGTTCAGGAGCCACATGTTGTCCGGGGATTGCCGCGCATTAGCACGTCTCAGACATCTAATCGTCGGTGGAGATAAAGTGGATTTTCACGCTGCGGTGTCCTTTTTGGAGCGTTCCCCCAATACGCAGCTATACAACGGTTACGGGCCGACGGAAAACACCGTTTTCACCACCGTTGCTCTGTTAGACCTTCACAAATTGAAACGTGAGAAACGGGTCCCAACAGGAAAGCTGGTCGGAGGAGGTGATTACCTTCTCTTCGATGAACACACCGGTGAATACCGAAAATCGGGTATTGGGAGGCTCCATGTAACGGGAAGAGGTCTGTCCCTGGGCTACCACGATAATCCCGTTGAAACCGGCAAGGTGTTTACGATAATTGACGGCACCCGTTATTACGATACCGGGGATATCGTCGAGTGCACATTAGATCGCGAATTTTATTTTTTGGGTCGGCAGGACCGTCAGGTTAAATTGAATGGGCACCGGGTTGAATTAGATGACATTGAAAAGACGTTAGAAAACGATCGGTCCATTGTGAAAGCACTGTGTTTTATATGGAATAGCCATCTTGTGTCTTTGATCGAAATACAGGATAAAACGGCAAATCTCGATACGATTGCTACCCGGTTGCGCTCTCAGTTGAGCTCCTTCTCTTTTCCTGATTTTTTAATCGAAAACACTCAGTGGCCGCTCACTAAGAATGGCAAAATCGATACAAAGTCCCTAATCAACCAGACGATAAACCATCTGGAAATGCGTCAAACCGATTCCGCCGGACGGTCGGTGAAGAGTGTTGCTGAACAGGTGTTGGATAAGCCGGTGGAACTACTTGATGCTGGTTTATTTGATCTTGGCTTTGATTCCATATCTATGCTCACGTTTAGTCACGAACTGAATAAACAATTTGATATTAAAATAAATCTTCTTGACCTTTATGTTGCTGGCACATTGCAAGGTGTGGATGATTTAGTCACCAACAAAATCAATGCCTAG	MQDDDLKNVLRTVRARYGQKNAIVFNEVACSYQELDRRIGICNQAISRSDTAVIINVKDKLKAITLMLAAIDCGVTFIPVDGDRPRSFLTKIATKFPQVRVINDVCFDTGLLVSHPLTHHGHAQVLPRAVEQGVMSVMYTSGSTGEPKGVQVRASSVLNLLHRPSFISLSDEDVVASYSSLSFDASTFEIFTPLLAGGTLVLLDKMVVLDEASLLHAIEQYRITCMWMTAGLFRSHMLSGDCRALARLRHLIVGGDKVDFHAAVSFLERSPNTQLYNGYGPTENTVFTTVALLDLHKLKREKRVPTGKLVGGGDYLLFDEHTGEYRKSGIGRLHVTGRGLSLGYHDNPVETGKVFTIIDGTRYYDTGDIVECTLDREFYFLGRQDRQVKLNGHRVELDDIEKTLENDRSIVKALCFIWNSHLVSLIEIQDKTANLDTIATRLRSQLSSFSFPDFLIENTQWPLTKNGKIDTKSLINQTINHLEMRQTDSAGRSVKSVAEQVLDKPVELLDAGLFDLGFDSISMLTFSHELNKQFDIKINLLDLYVAGTLQGVDDLVTNKINA	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	101.08	gnl|BL_ORD_ID|4935|hsp_num:0	5928			576	1638	colistin A; colistin B
BGC0000956.1|Andrimid_15 # 12955 # 13362 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.429	BGC0000956.1|Andrimid_15 	12955	13362	+	Loose	380	23.483	AcrS	50.0	3000656	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACTGAATATAATGAAAGTGAACTAAAAAACATTGAAATTGTAAAATCACTGTATACGGATGTTTTTGATACGGGCAATTGCCCGGTCGTGAACAGTTATTATCATGAGGGTGCGAAATGCCATTTAAAAGGTAAAACGCTCCATATTGAACAGATGAAAGGGGGGATGGGGGAATTTGTTGCAAAACATGCGTCGATCTCAACTTCGATCGAGTCGATCTTTGCTGCCGGTGACCGCACTTATGCCCGCCTTAATCGCCAGGCCACGTTAAAAGGTGAAGAGCAAGCCCGTGATATTGAGATCATGGTAGAAAAACGATTTGTTGATGGGAAAGTCGCAGAACTGTGGTTCATGGTCGATGACGAAATGTACAGCGAAATTTGGCTAAAACAGCCGTCAGCATAA	MTEYNESELKNIEIVKSLYTDVFDTGNCPVVNSYYHEGAKCHLKGKTLHIEQMKGGMGEFVAKHASISTSIESIFAAGDRTYARLNRQATLKGEEQARDIEIMVEKRFVDGKVAELWFMVDDEMYSEIWLKQPSA	MAKRTKAEALKTRQELIETAIAQFAQHGVSKTTLNDIADAANVTRGAIYWHFENKTQLFNEMWLQQPSLRELIQEHLTAGLEHDPFQQLREKLIVGLQYIAKIPRQQALLKILYHKCEFNDEMLAEGVIREKMGFNPQTLREVLQACQQQGCVANNLDLDVVMIIIDGAFSGIVQNWLMNMAGYDLYKQAPALVDNVLRMFMPDENITKLIHQTNELSVM	61.36	gnl|BL_ORD_ID|601|hsp_num:0	520			168	204	tigecycline; ciprofloxacin; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000956.1|Andrimid_16 # 13420 # 16053 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.483	BGC0000956.1|Andrimid_16 	13420	16053	+	Loose	750	67.781	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	26.05	3003463	protein variant model	G269S	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGGATATAGCGATCACTGGCTTCTCTTTTCTCTTGCCTGGCGCAAGTAATATGGAAGAGCTGGACGCGTTGTTGGAATCCGGTCAGGATGCGTTAACCGACCCTCGCTCCTGCGACACTCCTCGTGAAGGTTGGGTCAGTCGGGCGGGCTACGTGCAGGGAGTCGATCAGTTTGACTACGACTTATTCGGGATGTCACTGCGGGACAGTTACATCATTGAACCTCAACAACGCATGTTTATTCAATGTGCATGGCGGGCATTGGAACAGGCTGGCTACAACCCGACCCGCTGTGCACTGAACGCTGGTGTCTACTCTACATCTTCCGACAGCCATTACCCCTCTTTTCTTTCAGACAGCCAGTTAGCATTGGATAAGTACGACCCTTTCGAGATCGAGATTGGCTCGAACAAGGAACAGCAGTCATTGCGATGCGCATACCTGTTTGATCTGAAAGGTCCGGCTGTAGGAGTACAGTCAGCATGCTCAAGCGGCTTACTTTCTGTCCACATGGCGATGCAAGGGATCGCAACCGGAGACTGTGATATGGCCATCGCGGGCGGAGCCTGCCTGCCTTATCCTCTTCATTCCGGGTATCAGTTCCAACCGGGCATGAATCTGTCGGAAAGCGGTGTTTTATCCTCTTATTCTCACACGGCTGATGGCATGGTGCCCGGGTTTGGCTGCGTGGTGTTTGTGCTGAAATCCCTGGATAAGGCTCGCAGCGACAAAGACAGGGTATATGGTGTGCTTACCGCGAGCAGCATTAACAATGACGGAAGAGCGAAATCGAGTTATACCGCGCCTTCAACCAGTGGTATCGCCAGAAACATCCAAAATGTGCTCGCCAAATCGGCACTGAGGGTGCAGGACATCGACTTTGTTGAAGGTCACGGGTCGGGGACCAAAATTGGGGATGTGCTGGAAGTCGCGGCACTGAAAAAAGTCTTCATGAGTGACGAGCTGGCTGCCAACAGCACGGCTCTGTCATCAATTAAAGCCAATATTGGCCATTTGGATGTCGTTGCCGGTCATGCTGGCCTGTTAAAGTCTGTACTGCAAGTGTGGAACCATAAGCTCTATCCTGCAGCCAATTTCTCATCGCTTAACCCGAATCTACCACTGGAGCGGACGCCTTTTTATGTCCCCACAAAAAGTCATAGAAAAGAGAATTTAACAGGCCTGGTTAACTCTTTAGGGATCGGTGGAACCAACTGTGCGCTAGTTATTCGTGGGGAAGAGCGCGTTTCATTGGTCGTGGAAGACACGCCGCAGACAGTCGTCGTCATGATTGGTGCAAACAGCAGTGGGCGCTTGCAGCACCTGTTGTGCCAGCTCCAGGAAGAATTAAAGAACACCTCTCATTCGCTGAACGATGTGGCCTACACCCTGACAAGACGTTCTGTGGGGAAAAGCTGTATTGCGACCTTTGCTGTTGCATCTCTGAGCGAGCTTGAACAGCAAATTGCCGCCACATTGCGATCAGACGTTGTCGGTCAGCCCCTCGACGTATGTCTGAAGGAGTATACGGGGAAAGCGATCGCGCTTAACGCGAGCGAAATTGATGCCGAACGCGTCGTCACGATCCAGTCAACCCCTAAACCGCAAGCCCAGGTGGACGAAGTTCCGCGGGAAGCCACTACAGAAAATGTGGTTAGCTGCGAAGAAGCACTGCGTGAGATTTGGCTGGATAATTTTATGCTGGACTCGATAAACGAAGAAGATAGCTTCGCCGACCTGGGGGGGCACTCTATCCTCGCACTGTCACTGGTCACTGATATCAATACCGCACTCGGTCTGACTTTGACGATGGAGTGGGTTGAGAACTACGATGTTTTCAATGCGCAGCTGGAAGAACTGAACAGACTGGTCAGCACTAAAACAGCATCTTCACTAATAAAAACGCTGTGTGTTCCGCCTGGTGAAAAACGAGCAACGCTTATATTGATTCACGCATCGATTTCAGGCGTGGAAATGTACAAAAACCTGTCGAAAAAAATTTCCGGTGACATCGAGGTGCTCGGGGTCGACTCGTATAATCTCTATAATGAAAACAAAATTAGCTCAATAGAGAAACTCGCGGAAAAATATGCAGCTGATATTTTCGAGAGTGTGAAAAATAGCACTGCTCCAGTCTTTATTGGCGGCTGGTCACTCGGTGGGTTACTGGCTATTAAAATAACGGAATTATTAAGAGGGAAAATAGAAATAAGAGGCAATGTATTGCTGGATTCTGTTCTGTATTCTCCGGTTAGTTCAGTGCTTTTTACTGATGACTATCTCTCCTGTTTTATGGATCTCAGCTATTTTTCAAATTCGATCACCGGAGATGAGAGAGCAAGGGATAATCTTAAATCATTATTTGATATAGAAAGAAATATGGTTAAGGAGTTTGAGTATTCTGGGATCACCTTGCCCCTGCTCAACGTCGTTGCGACCGCTTCTCTTGTACAGATAAAAAACAACATGCTCTCTAATGCATTTGAGTCGTTGAAAAAGGCCAACAATAACTGGCCGGTGAGCGATTTAATGATGGTCAGAAAAATCAACACTGACCATGTTGGATTAGTCACTGAATCAAATGTTGATGACGTTTCAGGATTCATTCGGGAGTTTTTAGAACAGCATGTATAA	MDIAITGFSFLLPGASNMEELDALLESGQDALTDPRSCDTPREGWVSRAGYVQGVDQFDYDLFGMSLRDSYIIEPQQRMFIQCAWRALEQAGYNPTRCALNAGVYSTSSDSHYPSFLSDSQLALDKYDPFEIEIGSNKEQQSLRCAYLFDLKGPAVGVQSACSSGLLSVHMAMQGIATGDCDMAIAGGACLPYPLHSGYQFQPGMNLSESGVLSSYSHTADGMVPGFGCVVFVLKSLDKARSDKDRVYGVLTASSINNDGRAKSSYTAPSTSGIARNIQNVLAKSALRVQDIDFVEGHGSGTKIGDVLEVAALKKVFMSDELAANSTALSSIKANIGHLDVVAGHAGLLKSVLQVWNHKLYPAANFSSLNPNLPLERTPFYVPTKSHRKENLTGLVNSLGIGGTNCALVIRGEERVSLVVEDTPQTVVVMIGANSSGRLQHLLCQLQEELKNTSHSLNDVAYTLTRRSVGKSCIATFAVASLSELEQQIAATLRSDVVGQPLDVCLKEYTGKAIALNASEIDAERVVTIQSTPKPQAQVDEVPREATTENVVSCEEALREIWLDNFMLDSINEEDSFADLGGHSILALSLVTDINTALGLTLTMEWVENYDVFNAQLEELNRLVSTKTASSLIKTLCVPPGEKRATLILIHASISGVEMYKNLSKKISGDIEVLGVDSYNLYNENKISSIEKLAEKYAADIFESVKNSTAPVFIGGWSLGGLLAIKITELLRGKIEIRGNVLLDSVLYSPVSSVLFTDDYLSCFMDLSYFSNSITGDERARDNLKSLFDIERNMVKEFEYSGITLPLLNVVATASLVQIKNNMLSNAFESLKKANNNWPVSDLMMVRKINTDHVGLVTESNVDDVSGFIREFLEQHV	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	210.82	gnl|BL_ORD_ID|1968|hsp_num:0	1943			504	1239	isoniazid
BGC0000956.1|Andrimid_17 # 16046 # 16360 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.413	BGC0000956.1|Andrimid_17 	16046	16360	+	Loose	1900	23.483	acrB	44.44	3000216	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTATAAGCATATTATTTTATTTAAATTCCAGACGTCTGTTTCTACAGCGGAGGCTCTGGAACTGCTTCACCAGCTAGGGGAGTTGAAAGATAAAATCCCCGGCATCGTAAAATACAGCTATGGAAAGAATGATGGCGACAATACGCATAATTTAGGCTTTGAGTATGCATTCGTTATGGAATTTAGCTCGAAACAGGACAGAGACGCCTATCAAATCAATGAGCACCATCAAACGTTTATTAACAAAACACTGAACTCTGCCATTTCAGAGGCGATTGTCTTCGATATGGTTGTGGCCGGGGAAGAGAGATGA	MYKHIILFKFQTSVSTAEALELLHQLGELKDKIPGIVKYSYGKNDGDNTHNLGFEYAFVMEFSSKQDRDAYQINEHHQTFINKTLNSAISEAIVFDMVVAGEER	MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISASYPGADAKTVQDTVTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQEVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGSQYAMRIWMNPNELNKFQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANALDTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFEKSTHHYTDSVGGILRSTGRYLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTHYYLTKEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKDAMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLAEAAKHPDMLTSVRPNGLEDTPQFKIDIDQEKAQALGVSINDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYRMLPDDIGDWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAMELMEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLIEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIFFVPVFFVVVRRRFSRKNEDIEHSHTVDHH	9.91	gnl|BL_ORD_ID|1011|hsp_num:0	1104			2505	2577	tigecycline; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000956.1|Andrimid_19 # 19283 # 21007 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=ACA;rbs_spacer=14bp;gc_cont=0.479	BGC0000956.1|Andrimid_19 	19283	21007	+	Loose	1000	76.2554	almE	24.18	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGAATTCTACATTTATCGAAAAGTTTGAATCTATTGCGGAATTATTCCCCACAAATATTGCACTCATTGCTGGCCATCGTTCAATCACGTACTCTCAACTTCAACATCAGGCAAAGAGGATTGCTGCCGGTATCCAGTCTGAAATCGATGACAACGTCGAGGGCGTGGTACTGTGTTTACAGAGAGATGAATCGCTGATTGCCACGATATTAGCATGCCATTACCTTGGGATACCGTATATCCCTGTAGACCCCAGAACCACATACGAGAAAATCGATCATATCCTCTCCCAGGCGCGTTACTTGTATATCAGTAACGTGAAGATAAGCGAATACCAAAAAACACTGGACGTCATTAGCCAGTTAAACGCTAATACCCCTTTTGAACATAAAAGCCTGACACGTGCATCTCAAGAGGCTTATCGAATATATACGTCTGGCTCAACCGGTGCGCCCAAAGCGGTGATGGTCAGCCATATTGGGTGTGCTAACTTAATTGAGTACTTTTGCCACTTATTAGCATTCAGGCCCGGGCAGACATGGTTATCCTCAACGTCGATTGCCTTTGATATTTTCTTCCTGGAATACTCAGTCCCCCTGGCGAGTGGGGGGACCTTAATATTGCTGACAGATCAAGAGATCTACTCGCCGCAACAGATCGCAGGACAAGTGATGCGCTGGTCACCTTCCGTCTACCAGGCCACGCCTTCGCTGTTCAAAGGGCTGTTAGGCTATCTGGAGCAGGGGTGGCACTTCCAAAAAGTATTAGTGGGTGGTGAAGCTCTGTCTCCACAGCTGTCTTCAGCGTTGTTTGCACGAAGTGACTGGCTGTGCAATGTGTATGGACCCACAGAAACCACCGTCTGGTCTGGTGCGCATGTCATTCGACAAGCAGGGGACACCCGTATTGGGCAAGCAATACGCAATACCCAGATCCTGATATTGAACGAGTGTCAGCAAGAGTGCGCACAGGGTGAGCCGGGTCGAATTTATATTTCCGGGGATGGCCTGGCGTTGGGTTACTTTAATAACCCTGAGTTGACGGCGAGTAAATTCACAGAATTGTGCATCGGGGGTGTCAATCGACGGATGTATGATACCAATGATATTGGTTATGTGGATAACGAAGGCATCGTCAATTTTCTTCACAGAGAAGGTGGGTTTATCAAAATCAATGGGTATCGAGTAGAACCATCGGAAATAACGGATACGTTTGAAGCGATTGCGGGCGTGTCTGGTTCTGCGGTCATTTGCCTTCATGACGAACTGTCTGATTCCGCAAAACTGATAGGCTGGGTGGAGTGCACGGAGGTGACTGAGGCAGCGATAAGGGCATTTCTTCAGTCAAAGTTAAGTTACTATTTGATCCCTCATCATATTTTCACTATCCCGGCATTGCCTTACACGCTGAGCGGTAAAGTCGACGGAAACAGGCTTGAAGAGATGAGCCTCAGTCTTTTGAGTCAGACGCCCACGGCCAGTGCCTCCGCATCAGAGGGCGAACCATCCGCTCTGGCATCCCATCCTGTGGGTAAGATCCTGGGTCAGTATATGGACATCACCCGGATGTCAAAAGACGACAACTTCTTTGAACTGGGGTTAACGTCGATGCAGGCCATCTCTCTGCATCTCGATATGCTTGAGTTATACCCCAACTTACAGCTGCACGAAATCTTTGAGCGGCCATCTTTCGATAAGCTGATAAATGAACTTGAGTGCATATAA	MNSTFIEKFESIAELFPTNIALIAGHRSITYSQLQHQAKRIAAGIQSEIDDNVEGVVLCLQRDESLIATILACHYLGIPYIPVDPRTTYEKIDHILSQARYLYISNVKISEYQKTLDVISQLNANTPFEHKSLTRASQEAYRIYTSGSTGAPKAVMVSHIGCANLIEYFCHLLAFRPGQTWLSSTSIAFDIFFLEYSVPLASGGTLILLTDQEIYSPQQIAGQVMRWSPSVYQATPSLFKGLLGYLEQGWHFQKVLVGGEALSPQLSSALFARSDWLCNVYGPTETTVWSGAHVIRQAGDTRIGQAIRNTQILILNECQQECAQGEPGRIYISGDGLALGYFNNPELTASKFTELCIGGVNRRMYDTNDIGYVDNEGIVNFLHREGGFIKINGYRVEPSEITDTFEAIAGVSGSAVICLHDELSDSAKLIGWVECTEVTEAAIRAFLQSKLSYYLIPHHIFTIPALPYTLSGKVDGNRLEEMSLSLLSQTPTASASASEGEPSALASHPVGKILGQYMDITRMSKDDNFFELGLTSMQAISLHLDMLELYPNLQLHEIFERPSFDKLINELECI	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	103.24	gnl|BL_ORD_ID|4935|hsp_num:0	5928			228	1653	colistin A; colistin B
BGC0000956.1|Andrimid_20 # 21094 # 22287 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=ACA;rbs_spacer=14bp;gc_cont=0.518	BGC0000956.1|Andrimid_20 	21094	22287	+	Loose	700	62.3882	cmx	23.99	3002703	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCCTGAGAAGAAAGTCATCTGGTTGATGGCACTTATTCAATTTATTAATGCTGTGGATTTTATGATCGTTATGCCTCTCGGAGCCGATCTTGCTGGGGCATTACATATGTCGGCGGCAAACATGGGTTATCTTGGGGGAGGTTACACTCTGGCTGCCGCCGTCTCTTCACTGCTGGTGGCGAAGTATATTGACAGGTTCGATCGTAAACGGGTGGTGTTAGTCATGTTGACCGGATTGTCAGCAGCTACCTTGATGTGCGCGCATACCTGGAATATGAACAGCCTGATGTTTGCCCGCATTCTTGCCGGCTTTTTTGCCGGTCCATTAGTCGCTATCTCTCTGGCCATTTTGACGGACTGTGTCCCCGCAGAGCGTCGTGGGCGAGCCATGGCTACTGTGATGGGGGCTTTTTCCATTGCTGCGATTGCTGGCGTGCCTTTGAGCCTCAAGCTGGCAACTATGTATGACTGGTCCACGCCTTTTCATGTCGTCGGTGCATCAGGAATGCTGGTGGCAGCCATGGTGATGGTATTACTGCCAGGCCTGAAAGGGCACCTTCAGGGAACGGCGTCCGTACCGCCTGATGTGTCTCTGCTGGCATTAATGTCTAATCGCCGGGTTGTGCTGGCGATTTCCTCGCTGGGCCTGGCCGTATTAAGTACGTTTCTTTTGTTACCGAATCTGGCCGTTTGGCTGCAACTCAACGCTGGCGTCGCCCGCGACGATTTAAGTATGTATTACCTGATCGGGGGAGGAGTCAGCGTGATTGCGCTACAGATTTGTGGTCGCATGGTTGACAAAATAGGGCCGCTCTTCGTGGCGATTGGTCTTGCAGTCGGTATCTTTGCTGTGATTTTCGACGGTTTTATGCATCCTTCTTTCTTACCTCCGGTGATTGTTTTTACGGCATTTACTGCGTTGACGGCAACGCGAACCATTGTTGCCGCCACAGTCAATACCACCGTACCAGCCCCTAACGTAAGAGCGGCTTTTATGTCTCTTCAAAGCATCTGCCAACATGTGTTTAGTGGCTTAGCTGCCATCCTCTCGTCATGTATTCTGGTAGAAGAGCAACAAAAGCTGCTCAACCTTGAGATATTGGCCGCCTGTGCGTTAGCCCTCACGCTCGTGCAGCCACTGGTCTTACAGCGACTGCTCAGGCATCAAAAGCTGTCACCTGCCACGCCATAA	MPEKKVIWLMALIQFINAVDFMIVMPLGADLAGALHMSAANMGYLGGGYTLAAAVSSLLVAKYIDRFDRKRVVLVMLTGLSAATLMCAHTWNMNSLMFARILAGFFAGPLVAISLAILTDCVPAERRGRAMATVMGAFSIAAIAGVPLSLKLATMYDWSTPFHVVGASGMLVAAMVMVLLPGLKGHLQGTASVPPDVSLLALMSNRRVVLAISSLGLAVLSTFLLLPNLAVWLQLNAGVARDDLSMYYLIGGGVSVIALQICGRMVDKIGPLFVAIGLAVGIFAVIFDGFMHPSFLPPVIVFTAFTALTATRTIVAATVNTTVPAPNVRAAFMSLQSICQHVFSGLAAILSSCILVEEQQKLLNLEILAACALALTLVQPLVLQRLLRHQKLSPATP	MPFALYMLALAVFVMGTSEFMLAGLLPAIATELDVSVGTAGLLTSAFAVGMVVGAPVMAAFARRWPPRLTLIVCLLVFAGSHVIGAMTPVFSLLLITRVLSALANAGFLAVALSTATTLVPANQKGRALSILLSGTTIATVVGVPAGALLGTALGWRTTFWAIAILCIPAAVGVIRGVTNNVGRSETSATSPRLRVELSQLATPRLILAMALGALINGGTFAAFTFLAPIVTETAGLAEAWVSVALVMFGIGSFLGVTIAGRLSDQRPGLVLAVGGPLLLTGWIVLAVVASHPVALIVLVLVQGFLSFGVGSTLITRVLYAASGAPTMGGSYATAALNIGAAAGPVLGALGLATGLGLLAPVWVASVLTAIALVIMLLTRRALTKTAAEAN	101.53	gnl|BL_ORD_ID|1252|hsp_num:0	1366			12	825	chloramphenicol
BGC0000956.1|Andrimid_21 # 22422 # 23087 # 1 # ID=1_21;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.521	BGC0000956.1|Andrimid_21 	22422	23087	+	Loose	400	25.0238	QnrVC4	32.26	3002801	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic target protection	quinolone resistance protein (qnr)	TTGGTTCTTTGGTTCAATGCCTTCGAGCTCAGATATTTCGAACAGTCACTCTTCCATGATTTCGGTGTGGAATGCCCCACGCTGCTAACCGGAGCAGTGCCAAAAAGAAAGGCCGAGTACTTTGCCGGTCGACTGGCTGCCAGACGTGCGCTCCAGTTCCTTGGCTGCAAAACACTCGCTCTTCCCATCGGGGAGCACCGACTTCCGCAGTGGCCTTCGGGCTACCGTGGGTCCATTTCTCACACGCGGGCATTAGCGGTGTCGGCTGTCTGTCATCAGGAACACTACCAGGCCGTGGGGATTGATACAGAAATAGTATTCACGGCCGATCAATGTACCAGATTAACGAGTGCCATCGTGTCTGAAGCCGAATGGAATGACGTTATTCGAGGTGGTTGCACTCTCGCGCATCCGCAACTGGTCACTCTGATTTTTTCAGCCAAAGAAGCCTTGTATAAAGCACTTTTTCCCCACACGTTGCTGTTTCAGAATTTCAGTGCCGCAAGGCTGACATGGATATGTGAAAAAACGGCACAGTTTCAGATTGAACTCACCTGCGAGTGGAGTGGAGGCTATCGTACGGGCTCTCATTTTACTGGGTGGTTTCGGTTTTTTGATCATACCGTTGTCACAGTGATTGCTGACGGCCCCCCGCCAGCCCACTGA	MVLWFNAFELRYFEQSLFHDFGVECPTLLTGAVPKRKAEYFAGRLAARRALQFLGCKTLALPIGEHRLPQWPSGYRGSISHTRALAVSAVCHQEHYQAVGIDTEIVFTADQCTRLTSAIVSEAEWNDVIRGGCTLAHPQLVTLIFSAKEALYKALFPHTLLFQNFSAARLTWICEKTAQFQIELTCEWSGGYRTGSHFTGWFRFFDHTVVTVIADGPPPAH	MDKTDQLYVQADFSHQDMSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD	101.38	gnl|BL_ORD_ID|408|hsp_num:0	452			468	561	ciprofloxacin; levofloxacin; moxifloxacin; gatifloxacin; nalidixic acid; norfloxacin; sparfloxacin
BGC0000956.1|Andrimid_22 # 23259 # 24140 # 1 # ID=1_22;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.431	BGC0000956.1|Andrimid_22 	23259	24140	+	Loose	600	25.0238	clbC	35.42	3002816	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	TTGAATTCTGAAGATATTAAGGCGCTATATACTGAACGCAAGCCAACAAAGCATGATGATTATTATCATGATATTTCAGGCTCTGTGAGTGAAATATTTAAGGTGGCAAGGAATATAGTAGAGCATTATAAAGGGATAAATAAATATAACATTAATCCGGAAAGGTACAACGACATTGATATCACCCAGCCTGAAATCATACTGGACAGATTGTCTGACGCTGGTGTGACATCCATTATTAACCCGATCCCCTTTGAACATAAGCTCGTCGGACATTGTTTGACCCTGGCGATCGTGGCGCTTGACATGATGAGGTACAAAAACATCCCTTCCCGATTACGGTACGCCTATTGCACCTACTTCAGTCAGGATATTTACCCAGAGCAAATTCTGATTGAATACTGGTGTGAGGACAAGGGGGCATGGTTATTGGGTGACCCCTCGATGAACCAGGAAGTGCTGGATCACAATCAGATTTCGGTAAACGTGGATTTTTGCAATGTGGATAACACGCTGTCTCAGCCGATCTACCAGGTATGGTATCACCTAAGGAAAGGTAAGCTGGATTTCACTATGTATCGTGGTATCAATGACAGGCAAGAAAGAAAACAGGTATTAGAAGAGGTGGCCCGGATATTTGTGAATGACCTGGCAATGATGAACAATCTTTTATTATCGATTTATGATTATGTCCTGACCCCGTATCAGTCGGACCATCTCAGCGCAGAGTTGCTGCAATATCTGGATGAGATTGCAGATGAAATGATGGCCTCGCCAGGTTGCCTGATCGCTTACGATGAATCCAATCTTATCCGCTACCGGCCACGAACTGCGGTGAGAAAGAGTGTCTTCAGAAGAGAGGAAGAGATATTTGATGTATAA	MNSEDIKALYTERKPTKHDDYYHDISGSVSEIFKVARNIVEHYKGINKYNINPERYNDIDITQPEIILDRLSDAGVTSIINPIPFEHKLVGHCLTLAIVALDMMRYKNIPSRLRYAYCTYFSQDIYPEQILIEYWCEDKGAWLLGDPSMNQEVLDHNQISVNVDFCNVDNTLSQPIYQVWYHLRKGKLDFTMYRGINDRQERKQVLEEVARIFVNDLAMMNNLLLSIYDYVLTPYQSDHLSAELLQYLDEIADEMMASPGCLIAYDESNLIRYRPRTAVRKSVFRREEEIFDV	MKVVNHATKYERLKHFLNALNEPTYRYKQITEAIFKHRIGAFNKMTTLPKALRESLINEFGPSILTVEPVLETTSQQVTKVLLKVAGNNQVEAVRMHYEAGWESFCISSQCGCGLGCTFCSTGAIGLKQNLSADEMTDQLLYFYLKGHSLDSVSFMGMGEALANVRIFDALNVLVDRQLFALSPRRITVSTVGIIPNIQRMTSSFPQMNLTFSLHSPFHDQRSELMPINNKYPLDQVMNVLDQHIHETGRKVYIAYVMLRGVNDSEKHAEALVKRILNNRYPHLYHVNLIRYNPTVGTPENYGQTIEEKLQTFYRVVKSARIPVTIRSQFGREIDAACGQLYGQYQAKKR	83.71	gnl|BL_ORD_ID|1512|hsp_num:0	1642			708	837	lincomycin; clindamycin; azidamfenicol; chloramphenicol; thiamphenicol; virginiamycin M1; tiamulin; madumycin II; griseoviridin; dalfopristin
BGC0000956.1|Andrimid_25 # 25544 # 25744 # 1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.463	BGC0000956.1|Andrimid_25 	25544	25744	+	Loose	800	21.9422	Staphylococcus aureus LmrS	46.15	3004572	protein homolog model	n/a	n/a	macrolide antibiotic; aminoglycoside antibiotic; oxazolidinone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAAAAAGTCACTATTCAGCGAAGAACAGATTGTCTTTGCTCTGAGGCAGGCTGAACTGGGTACGTTCGTACCTGAAATTTGCCCTGAGCTGGGCATTTCAGAAGCAACATTTTTCACTTACATAAAAATATTGAGGGATTGCTTTTCCAGGCTGATCGTCCCGCGTGAGTGCATCGCTCTGCCATCTGGCCGAGCATAA	MKKSLFSEEQIVFALRQAELGTFVPEICPELGISEATFFTYIKILRDCFSRLIVPRECIALPSGRA	MAKVELTTRRRNFIVAVMLISAFVAILNQTLLNTALPSIMRELNINESTSQWLVTGFMLVNGVMIPLTAYLMDRIKTRPLYLAAMGTFLLGSIVAALAPNFGVLMLARVIQAMGAGVLMPLMQFTLFTLFSKEHRGFAMGLAGLVIQFAPAIGPTVTGLIIDQASWRVPFIIIVGIAILAFVFGLVSISSYNEVKYTKLDKRSVMYSTIGFGLMLYAFSSAGDLGFTSPIVIGALILSMVIIYLFIRRQFNITNALLNLRVFKNRTFALCTISSMIIMMSMVGPALLIPLYVQNSLSLSALLSGLVIMPGAIINGIMSVFTGKFYDKYGPRPLIYTGFTILTITTIMLCFLHTDTSYTYLIVVYAIRMFSVSLLMMPINTTGINSLRNEEISHGTAIMNFGRVMAGSLGTALMVTLMSFGAKIFLSTSPSHLTATEIKQQSIAIGVDISFAFVAVLVMAAYVIALFIREPKEIESNRRKF	13.75	gnl|BL_ORD_ID|2869|hsp_num:0	3276			69	147	erythromycin; streptomycin; kanamycin A; linezolid; trimethoprim; chloramphenicol; florfenicol
BGC0000956.1|Andrimid_26 # 25791 # 26057 # 1 # ID=1_26;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.476	BGC0000956.1|Andrimid_26 	25791	26057	+	Loose	550	24.6386	lnuF	29.73	3002839	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic inactivation	lincosamide nucleotidyltransferase (LNU)	TTGGGAGAAGACCAAAAAGCGTTTGGATGGGATGGTCGGGATGATAATGACAACCTAATAAGTAAAGCCCACCCAGAAGGACGAAACGCATCTCACATCAGTAGTAGTCCTCCAAAGAAAAACGGTATAACGACGATTTCCTATCAATGGGCCATCACTCAGCAATTGGAAAAGAAACACCATGCGGTGGTAGAGATACTGCGGCAGTGCGGGGCGCAGAATTGTTGTCTCCGGCGGTTTACCTTCTCTGGGGAAAAGATGATGTGA	MGEDQKAFGWDGRDDNDNLISKAHPEGRNASHISSSPPKKNGITTISYQWAITQQLEKKHHAVVEILRQCGAQNCCLRRFTFSGEKMM	MLQQKMIERFKEACHEDARIIAALMFGSFAIGEGDEFSDIEFAVFIQNNHFENFDQRSWLNAVSPVAAYFPDDFGHHTALFENGIRGEFHFMRKSDIPVISTWQGYGWFPSLEEAVLLDRSGELSRYASALVGSPPKREGAPLVEGLVLNLISLMLFGANLLNRGEYARAWALLSKAHENLLKLVRLHEGATDHWPTPSRALEKDVSEDSYNRYLACTGSAEPKALCVAYHETWKWSLELFRSVAGPLNIELPRIVIAQTKRLLNESATPHNK	32.23	gnl|BL_ORD_ID|1373|hsp_num:0	1491			309	420	lincomycin; clindamycin
BGC0000956.1|Andrimid_28 # 26834 # 27409 # -1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.354	BGC0000956.1|Andrimid_28 	26834	27409	-	Loose	450	31.187	cphA2	27.43	3003099	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CphA beta-lactamase	ATGAAAAAAATATTATTATCTTTCGCAGTTATAGCCATTTTTTTCATGTGTAATTACACGTATTCTTACCCCGAACAGACTTCCTTTAAAAGCAACGCTGCCACCTCCCCTACCGCTCAGGTGGCAAGTTTAGTTGAAAAGTTGGTTATGGCTGACACTAAACAGAGTAAAAAAATTCTTGCTGAAATAGATTCAATCCGTAGAGAAAACCCAGAAAACACCGACATCCTGTTAATGTATGCAAACAGTCTCATAGGCGAAAAACAATACAAGCAAGGAATTAACTCCCTCAGGGCTCTCTATGAAAAAAAACCAATTCGTACGTATTTACTTACACAGTGCATGTTAAAAGAAAGGTTGGGTAATAAGGATAAAAGCTGTTACGACGAAGTCGTACATCTTTCTGAACAAAAAGATTTGATAGATTCCGATTATATAACAGCTCTTTTCTTTTCCGATACAGAAAAGTTCAAAAGCGTAAAAAAACAACTTATCAAAAAAAAGGAAGTTAAGAAAAGTGATTTTCTTATTTATACGTTGGGCCAGAAAGAGATGCTGCATGAACTTTTCCCCTAG	MKKILLSFAVIAIFFMCNYTYSYPEQTSFKSNAATSPTAQVASLVEKLVMADTKQSKKILAEIDSIRRENPENTDILLMYANSLIGEKQYKQGINSLRALYEKKPIRTYLLTQCMLKERLGNKDKSCYDEVVHLSEQKDLIDSDYITALFFSDTEKFKSVKKQLIKKKEVKKSDFLIYTLGQKEMLHELFP	MMKGWMKCGLAGAVVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYVQENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSRQPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHEGDFTLQEGKLRAFYAGPAHTPDGIFVYFPDQQVLYGNCILKEKLGNLSFADVKAYPRTLERLKAMKLPIKTVVGGHDSPLHGPELIDHYEALIKAAPQS	75.20	gnl|BL_ORD_ID|1310|hsp_num:0	1428			276	603	
BGC0000956.1|Andrimid_29 # 27411 # 27896 # -1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.372	BGC0000956.1|Andrimid_29 	27411	27896	-	Loose	700	26.1794	CMY-40	28.36	3002051	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CMY beta-lactamase	ATGATCGTTAGGGATTATGTTAGTTTTATCATGGAGGATACAATGGCAACAAAATCATTTAGATTTTCAACTTTAGGATTTTTAACCCTTGAGGGGGTGGGTGCTTTACATGCATCTTCAACCTTGCTTTTGAATGTGACTGAACATGATGTAAAAGAAGGAAAAAAGTTATTTATATCTGCTTCTATGTTGTGTAATGCAGCCAGAGCTTATGGCTCAGGCCAGGTTAAACCCTGGTGCATCGTAGAAAATAACATTGACCACAAAAAATACACTTTAGATGCCAGAGATAAATCTTTTGCGCTCACACATGATGAAATACTTATCGGAAGTGCGGAATTTATAATACCGGCCAAGAAGTATATCCAGCCAATGTTGACGATTGAGAGCGGTTATATTTTAGCTACTGGATATACAGGTTCAATAGCGCCTTTCCCAAAGAAGTCAACATCAAAAATTTACCTGAATAACTTCAGGCAGATTTAA	MIVRDYVSFIMEDTMATKSFRFSTLGFLTLEGVGALHASSTLLLNVTEHDVKEGKKLFISASMLCNAARAYGSGQVKPWCIVENNIDHKKYTLDARDKSFALTHDEILIGSAEFIIPAKKYIQPMLTIESGYILATGYTGSIAPFPKKSTSKIYLNNFRQI	MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGTLAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMAHWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGYTGGFGSYVAFVPEKNLGIVMLANKSYPNPVRVEAAWRILEKLQ	42.26	gnl|BL_ORD_ID|686|hsp_num:0	745			882	1083	
